Mir-522-3p targets transcription factor 4 to overcome cisplatin resistance of gastric cells

HIGHLIGHTS

  • who: Guofeng Ma and collaborators from the Department of General Surgery, Nantong Geriatric Rehabilitation Hospital, Nantong, Jiangsu, China Department of General Surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China have published the paper: MiR-522-3p Targets Transcription Factor 4 to Overcome Cisplatin Resistance of Gastric Cells, in the Journal: Journal of Oncology 400 300 * of 27/09/2022
  • what: GC cell resistance to DDP is the main reason for the reduced efficacy of DDP, which has become a major bottleneck for therapy of GC.
  • how: To further validate the hypothesis of . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?